Pyrazolopyrimidines as therapeutic agents
US6660744B1 · kind B1 · utility
271Cited by
11References
86Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2000 |
| Grant date | Dec 9, 2003 |
| Priority date | — |
| Expiry date | Sep 15, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to pyrazolopyrimidine derivatives which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.